4/13/2021 7:01:21 AM
Danaher Expects Q1 Core Revenue Growth To Be Above High-end Of Previously Communicated Guidance Range
2/23/2021 4:21:50 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 3/26/2021
2/1/2021 12:09:39 AM
Cytiva Acquires Vanrx Pharmasystems
1/28/2021 6:01:29 AM
Danaher Q4 EPS From Cont Ops $1.66 Vs $1.07 Last Year
1/14/2021 7:01:11 AM
Cepheid Gets Health Canada License For SARS-CoV-2, Flu A, Flu B And RSV Combination Test
1/13/2021 7:00:44 AM
Danaher Estimates Q4 Revenues Up About 38.5% Year-over-year
12/8/2020 4:21:53 PM
Danaher Declares Quarterly Dividend Of $0.18/share, Payable Jan. 29/ Record Dec. 28
12/8/2020 4:18:30 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18 , Record Date 12/28/2020
11/23/2020 8:02:38 AM
Beckman Coulter Launches Access SARS-CoV-2 IgG II Assay
11/10/2020 3:03:26 AM
Beckman Coulter Launches Access SARS-CoV-2 Immunoglobulin M Assay In Countries Accepting The CE Mark